Enabling Consideration Of Packaging In The Early Stage Of Combination Product Development

Since it is very costly to rework a drug formulation due to an incompatibility with its packaging, combination product regulation drives the early understanding of drug/container compatibility for the intended use. This poster provides two case studies to show how West assess drug/packaging interactions and demonstrates the importance and feasibility of taking the container system into consideration in the early drug development stage.